drugset / Trial / NCT03762785

Pharmacokinetics and Dynamics of Nebulized Dexmedetomidine

NCT03762785

Phase 1/2 Unknown 16 enrolled Assiut University
RandomizedParallel-groupDouble-blindPrevention

Summary

the aim of this study is to study the pharmacokinetics and dynamics of nebulized dexmetedomidine in children undergoing major abdominal cancer surgery.

Timeline

Start
2018-12-10
Primary completion
2020-01
Completion
2021-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexmedetomidine Other / unclassified 2 ug/kg Inhaled
Comparator Dexmedetomidine Other / unclassified 3 ug/kg Inhaled